Read + Share
Amedeo Smart
Independent Medical Education
Slomski A. Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes. JAMA 2022;328:817.PMID: 36066528
Email
LinkedIn
Facebook
Twitter
Privacy Policy